DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Forecasted to Post Q3 2017 Earnings of $0.64 Per Share

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Equities research analysts at Northcoast Research decreased their Q3 2017 earnings per share estimates for DENTSPLY SIRONA in a note issued to investors on Wednesday. Northcoast Research analyst E. Snyder now expects that the medical instruments supplier will post earnings per share of $0.64 for the quarter, down from their previous estimate of $0.78. Northcoast Research also issued estimates for DENTSPLY SIRONA’s FY2017 earnings at $2.66 EPS, Q1 2018 earnings at $0.59 EPS, Q2 2018 earnings at $0.74 EPS, Q3 2018 earnings at $0.71 EPS and FY2018 earnings at $3.02 EPS.

XRAY has been the subject of several other research reports. Credit Suisse Group restated an “outperform” rating and issued a $75.00 target price (up previously from $67.00) on shares of DENTSPLY SIRONA in a report on Thursday, July 13th. BidaskClub cut shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Friday, July 28th. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating and set a $71.00 target price for the company in a report on Tuesday, May 2nd. Goldman Sachs Group, Inc. (The) cut shares of DENTSPLY SIRONA from a “neutral” rating to a “sell” rating and lowered their target price for the company from $60.00 to $55.00 in a report on Tuesday, May 23rd. Finally, HC Wainwright started coverage on shares of DENTSPLY SIRONA in a report on Tuesday, July 11th. They issued a “buy” rating and a $74.00 target price for the company. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and nine have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $66.75.

TRADEMARK VIOLATION WARNING: “DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Forecasted to Post Q3 2017 Earnings of $0.64 Per Share” was first reported by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this piece on another website, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The original version of this piece can be accessed at https://stocknewstimes.com/2017/08/12/dentsply-sirona-inc-nasdaqxray-forecasted-to-post-q3-2017-earnings-of-0-64-per-share.html.

Shares of DENTSPLY SIRONA (XRAY) opened at 55.33 on Thursday. DENTSPLY SIRONA has a 1-year low of $54.49 and a 1-year high of $65.68. The stock’s 50 day moving average is $62.91 and its 200 day moving average is $62.30. The firm’s market capitalization is $12.69 billion.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.65 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.65. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. The business had revenue of $992.70 million during the quarter, compared to the consensus estimate of $1 billion. During the same period in the previous year, the firm posted $0.76 earnings per share. The business’s revenue for the quarter was down 2.9% compared to the same quarter last year.

A number of hedge funds have recently modified their holdings of the company. Commonwealth Bank of Australia boosted its stake in shares of DENTSPLY SIRONA by 19.0% in the second quarter. Commonwealth Bank of Australia now owns 1,626 shares of the medical instruments supplier’s stock worth $104,000 after buying an additional 260 shares in the last quarter. Acrospire Investment Management LLC acquired a new stake in shares of DENTSPLY SIRONA during the second quarter worth $113,000. Dupont Capital Management Corp acquired a new stake in shares of DENTSPLY SIRONA during the second quarter worth $116,000. Korea Investment CORP boosted its stake in shares of DENTSPLY SIRONA by 139.9% in the second quarter. Korea Investment CORP now owns 2,145 shares of the medical instruments supplier’s stock worth $139,000 after buying an additional 1,251 shares in the last quarter. Finally, Sphera Funds Management LTD. acquired a new stake in shares of DENTSPLY SIRONA during the second quarter worth $162,000. Hedge funds and other institutional investors own 95.17% of the company’s stock.

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 13th. Investors of record on Friday, September 29th will be paid a dividend of $0.0875 per share. This represents a $0.35 dividend on an annualized basis and a yield of 0.63%. The ex-dividend date of this dividend is Thursday, September 28th. DENTSPLY SIRONA’s dividend payout ratio is currently -10.09%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply